{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T12:10:11Z","timestamp":1717848611358},"reference-count":42,"publisher":"Spandidos Publications","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.3892\/etm.2015.2421","type":"journal-article","created":{"date-parts":[[2015,4,14]],"date-time":"2015-04-14T07:50:00Z","timestamp":1428997800000},"page":"2406-2414","source":"Crossref","is-referenced-by-count":4,"title":["XPD Lys751Gln and Asp312Asn polymorphisms and hepatocellular carcinoma susceptibility: A meta-analysis of 11 case-control studies in an Asian population"],"prefix":"10.3892","volume":"9","author":[{"given":"QI","family":"YANG","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YAN-FEI","family":"WEI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YUAN","family":"ZHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"GUANG-MEI","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2015,4,14]]},"reference":[{"key":"key20180108130355_b1-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20180108130355_b2-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"S206","DOI":"10.1016\/S1590-8658(10)60507-5","article-title":"The changing pattern of epidemiology in hepatocellular carcinoma","volume":"42","author":"Nordenstedt","year":"2010","journal-title":"Dig Liver Dis"},{"key":"key20180108130355_b3-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"743","DOI":"10.7314\/APJCP.2012.13.3.743","article-title":"Risk factors of hepatocellular carcinoma-current status and perspectives","volume":"13","author":"Gao","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180108130355_b4-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1073\/pnas.89.1.261","article-title":"Correction of xeroderma pigmentosum complementation group D mutant cell phenotypes by chromosome and gene transfer: Involvement of the human ERCC2 DNA repair gene","volume":"89","author":"Flejter","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180108130355_b5-etm-0-0-2421","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"key20180108130355_b6-etm-0-0-2421","first-page":"7430","article-title":"Functional significance of XPD polymorphic variants: Attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp\/Asp genotype","volume":"61","author":"Seker","year":"2001","journal-title":"Cancer Res"},{"key":"key20180108130355_b7-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10549-010-0863-6","article-title":"Meta-analysis of two ERCC2 (XPD) polymorphisms, Asp312Asn and Lys751Gln, in breast cancer","volume":"124","author":"Pabalan","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key20180108130355_b8-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"231","DOI":"10.7314\/APJCP.2013.14.1.231","article-title":"XPD Lys751Gln and Asp312Asn polymorphisms and gastric cancer susceptibility: A meta-analysis of case-control studies","volume":"14","author":"Yin","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180108130355_b9-etm-0-0-2421","first-page":"526529","article-title":"A case-control study on polymorphism of DNA repair gene XPD and susceptibility to hepatocellular carcinoma","volume":"24","author":"Xu","year":"2004","journal-title":"Tumor"},{"key":"key20180108130355_b10-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/ije\/dyi191","article-title":"Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma","volume":"34","author":"Chen","year":"2005","journal-title":"Int J Epidemiol"},{"key":"key20180108130355_b11-etm-0-0-2421","volume-title":"Association between the nucleotide excision repair (NER) genes polymorphisms and genetic susceptibility and clinical phenotype of hepatocellular carcinoma","author":"Xie","year":"2007"},{"key":"key20180108130355_b12-etm-0-0-2421","volume-title":"A case-control study on the association between single nucleotide polymorphism of DNA injury repair gene XPD, XRCC1 and hepatocellular carcinoma","author":"Su","year":"2008"},{"key":"key20180108130355_b13-etm-0-0-2421","first-page":"702705","article-title":"Study on the relationship between hepatocellular carcinoma and the interaction between polymorphisms in DNA repair gene XPD and environmental factors","volume":"30","author":"Zeng","year":"2009","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"key20180108130355_b14-etm-0-0-2421","first-page":"912914","article-title":"A case-control study on the polymorphism of gene XPD and the susceptibility of primary hepatic carcinoma","volume":"22","author":"Cui","year":"2010","journal-title":"Med J Chin People Health"},{"key":"key20180108130355_b15-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1186\/1471-2407-9-400","article-title":"XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk","volume":"9","author":"Long","year":"2009","journal-title":"BMC Cancer"},{"key":"key20180108130355_b16-etm-0-0-2421","volume-title":"A study on relationship between familial clustering of hepatocellular carcinoma and such factors as polymorphism of XPD genes, etc. in Guangxi popution","author":"Hu","year":"2012"},{"key":"key20180108130355_b17-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.7314\/APJCP.2012.13.9.4423","article-title":"Association of XPD and XRCC1 genetic polymorphisms with hepatocellular carcinoma risk","volume":"13","author":"Guo","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180108130355_b18-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MEG.0b013e328359a775","article-title":"Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus","volume":"25","author":"Gulnaz","year":"2013","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"key20180108130355_b19-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s13277-012-0546-5","article-title":"Polymorphisms of DNA repair gene XRCC1 and hepatocellular carcinoma risk among East Asians: A meta-analysis","volume":"34","author":"Li","year":"2013","journal-title":"Tumour Biol"},{"key":"key20180108130355_b20-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"e56722","DOI":"10.1371\/journal.pone.0056722","article-title":"The glutathione S-Transferase P1 341C>T polymorphism and cancer risk: A meta-analysis of 28 case-control studies","volume":"8","author":"Huang","year":"2013","journal-title":"PLoS One"},{"key":"key20180108130355_b21-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"key20180108130355_b22-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"key20180108130355_b23-etm-0-0-2421","first-page":"86","article-title":"Global Cancer Statistics, 2012","volume":"61","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"key":"key20180108130355_b24-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jhep.2008.01.022","article-title":"Novel advancements in the management of hepatocellular carcinoma in 2008","volume":"48","author":"Llovet","year":"2008","journal-title":"J Hepatol"},{"key":"key20180108130355_b25-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2005.12.026","article-title":"The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk","volume":"245","author":"Jiao","year":"2007","journal-title":"Cancer Lett"},{"key":"key20180108130355_b26-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1078\/1438-4639-00294","article-title":"Use of biomarkers to characterize functions of polymorphic DNA repair genotypes","volume":"207","author":"Au","year":"2004","journal-title":"Int J Hyg Environ Health"},{"key":"key20180108130355_b27-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0923-1811(99)00088-2","article-title":"Common pathways for ultraviolet skin carcinogenesis in the repair and replication defective groups of xeroderma pigmentosum","volume":"23","author":"Cleaver","year":"2000","journal-title":"J Dermatol Sci"},{"key":"key20180108130355_b28-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1093\/mutage\/17.6.463","article-title":"ERCC2\/XPD gene polymorphisms and cancer risk","volume":"17","author":"Benhamou","year":"2002","journal-title":"Mutagenesis"},{"key":"key20180108130355_b29-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/aje\/kwj189","article-title":"XRCC3 and XPD\/ERCC2 single nucleotide polymorphisms and the risk of cancer: A HuGE review","volume":"164","author":"Manuguerra","year":"2006","journal-title":"Am J Epidemiol"},{"key":"key20180108130355_b30-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/pros.21048","article-title":"No association between variant DNA repair genes and prostate cancer risk among men of African descent","volume":"70","author":"Lavender","year":"2010","journal-title":"Prostate"},{"key":"key20180108130355_b31-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4103\/0973-1482.113345","article-title":"Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: A meta-analysis","volume":"9","author":"Zhu","year":"2013","journal-title":"J Cancer Res Ther"},{"key":"key20180108130355_b32-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000339603","article-title":"Polymorphisms in XPD and hOGG1 and prostate cancer risk: A meta-analysis","volume":"89","author":"Zhu","year":"2012","journal-title":"Urol Int"},{"key":"key20180108130355_b33-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s11033-011-0710-9","article-title":"Association of ERCC2\/XPD polymorphisms and interaction with tobacco smoking in lung cancer susceptibility: A systemic review and meta-analysis","volume":"39","author":"Feng","year":"2012","journal-title":"Mol Biol Rep"},{"key":"key20180108130355_b34-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s11670-011-0079-2","article-title":"DNA Repair Gene Polymorphisms in the Nucleotide Excision Repair Pathway and Lung Cancer Risk: A Meta-analysis","volume":"23","author":"Mei","year":"2011","journal-title":"Chin J Cancer Res"},{"key":"key20180108130355_b35-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/JTO.0b013e3181e7fe2a","article-title":"ERCC2\/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: A meta-analysis involving 22 case-control studies","volume":"5","author":"Zhan","year":"2010","journal-title":"J Thorac Oncol"},{"key":"key20180108130355_b36-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"e43431","DOI":"10.1371\/journal.pone.0043431","article-title":"The effect of XPD\/ERCC2 polymorphisms on gastric cancer risk among different ethnicities: A systematic review and meta-analysis","volume":"7","author":"Xue","year":"2012","journal-title":"PLoS One"},{"key":"key20180108130355_b37-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-010-0751-0","article-title":"Associations between XPD polymorphisms and risk of breast cancer: A meta-analysis","volume":"123","author":"Jiang","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key20180108130355_b38-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s10549-010-0813-3","article-title":"XPD Lys751Gln polymorphism and breast cancer susceptibility: A meta-analysis involving 28,709 subjects","volume":"124","author":"Qiu","year":"2010","journal-title":"Breast Cancer Res Treat"},{"key":"key20180108130355_b39-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"e35220","DOI":"10.1371\/journal.pone.0035220","article-title":"Associations between XPD Asp312Asn polymorphism and risk of head and neck cancer: A meta-analysis based on 7,122 subjects","volume":"7","author":"Hu","year":"2012","journal-title":"PLoS One"},{"key":"key20180108130355_b40-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.4238\/2011.November.22.6","article-title":"Association between XPD Lys751Gln polymorphism and risk of head and neck cancer: A meta-analysis","volume":"10","author":"Yuan","year":"2011","journal-title":"Genet Mol Res"},{"key":"key20180108130355_b41-etm-0-0-2421","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.7314\/APJCP.2012.13.7.3299","article-title":"Association between XPD Asp312Asn polymorphism and esophageal cancer susceptibility: A meta-analysis","volume":"13","author":"Duan","year":"2012","journal-title":"Asian Pac J Cancer Prev"},{"key":"key20180108130355_b42-etm-0-0-2421","first-page":"281285","article-title":"DNA repair gene xeroderma pigmentosum group D 751 polymorphism and the risk on esophageal cancer: A meta-analysis","volume":"30","author":"Wu","year":"2009","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"}],"container-title":["Experimental and Therapeutic Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/etm.2015.2421\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T11:19:32Z","timestamp":1717845572000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/etm.2015.2421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,14]]},"references-count":42,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,4,14]]},"published-print":{"date-parts":[[2015,6]]}},"alternative-id":["10.3892\/etm.2015.2421"],"URL":"https:\/\/doi.org\/10.3892\/etm.2015.2421","relation":{},"ISSN":["1792-0981","1792-1015"],"issn-type":[{"value":"1792-0981","type":"print"},{"value":"1792-1015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,14]]}}}